Atlas Trials

Meryx, Inc.

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Meryx, Inc.

RecordFirmDate
Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL (NCT04872478)Meryx, Inc.2022-04-01
Pharmacokinetic and Safety Study of MRX-2843 in Adults With Relapsed/Refractory Advanced and/or Metastatic Solid Tumors (NCT03510104)Meryx, Inc.2018-05-22

Track Meryx, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.